Antidepressant-like effects of mineralocorticoid but not glucocorticoid antagonists in the lateral septum: Interactions with the serotonergic system

Behavioural Brain Research

Volumn 223, Issue 1, 2011, Pages 88-98

  Mostalac Preciado, Christian Roberto ^a   de Gortari, Patricia ^b   López Rubalcava, Carolina ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

Forced swimming test; Glucocorticoid receptors; Lateral septum; Mineralocorticoid receptors; Serotonin

Indexed keywords

CLOMIPRAMINE; CORTICOSTEROID; FENCLONINE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; SEROTONIN; SPIRONOLACTONE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID RELEASE; DEPRESSION; DRUG ACTIVITY; FORCED SWIMMING TEST; GENE EXPRESSION; LATERAL SEPTUM; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; ANTIDEPRESSIVE AGENTS; CLOMIPRAMINE; CORTICOSTERONE; DRUG INTERACTIONS; FENCLONINE; HYDROXYINDOLEACETIC ACID; IMMOBILITY RESPONSE, TONIC; MALE; MICROINJECTIONS; MIFEPRISTONE; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; SEPTUM OF BRAIN; SEROTONIN; SPIRONOLACTONE;

EID: 79955890533     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.04.008     Document Type: Article

References (115)

1. Aguilar-Valles A., Sanchez E., de Gortari P., Balderas I., Ramirez-Amaya V., Bermudez-Rattoni F., et al. Analysis of the stress response in rats trained in the water-maze: differential expression of corticotropin-releasing hormone, CRH-R1, glucocorticoid receptors and brain-derived neurotrophic factor in limbic regions. Neuroendocrinology 2005, 82:306-319.
2. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 2004, 29:185-193.
3. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology (Berl) 1988, 94:147-160.
4. Cadepond F., Ulmann A., Baulieu E.E. RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 1997, 48:129-156.
5. Calfa G., Bussolino D., Molina V.A. Involvement of the lateral septum and the ventral hippocampus in the emotional sequelae induced by social defeat: role of glucocorticoid receptors. Behav Brain Res 2007, 181:23-34.
6. Calfa G., Volosin M., Molina V.A. Glucocorticoid receptors in lateral septum are involved in the modulation of the emotional sequelae induced by social defeat. Behav Brain Res 2006, 172:324-332.
7. Calogero A.E., Gallucci W.T., Chrousos G.P., Gold P.W. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 1988, 463:28-36.
8. Campioni M.R., Xu M., McGehee D.S. Stress-induced changes in nucleus accumbens glutamate synaptic plasticity. J Neurophysiol 2009, 101:3192-3198.
9. Carvalho L.A., Pariante C.M. In vitro modulation of the glucocorticoid receptor by antidepressants. Stress 2008, 11:411-424.
10. Cervo L., Grignaschi G., Rossi C., Samanin R. Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. Eur J Pharmacol 1991, 196:217-222.
11. Consoli D., Fedotova J., Micale V., Sapronov N.S., Drago F. Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). Eur J Pharmacol 2005, 520:100-107.
12. Contreras C.M., Alcala-Herrera V., Marvan M.L. Action of antidepressants on the septal nuclei of the rat. Physiol Behav 1989, 46:793-798.
13. Contreras C.M., Chacon L., Rodriguez-Landa J.F., Bernal-Morales B., Gutierrez-Garcia A.G., Saavedra M. Spontaneous firing rate of lateral septal neurons decreases after forced swimming test in Wistar rat. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:343-348.
14. Contreras C.M., Marvan M.L., Alcala-Herrera V., Guzman-Saenz M.A. Chronic clomipramine increases firing rate in lateral septal nuclei of the rat. Physiol Behav 1990, 48:551-554.
15. Contreras C.M., Marvan M.L., Ramirez-Morales A., Munoz-Mendez A. Clomipramine enhances the excitatory actions of dorsal raphe nucleus stimulation in lateral septal neurons in the rat. Neuropsychobiology 1993, 27:86-90.
16. Contreras C.M., Rodriguez-Landa J.F., Gutierrez-Garcia A.G., Bernal-Morales B. The lowest effective dose of fluoxetine in the forced swim test significantly affects the firing rate of lateral septal nucleus neurones in the rat. J Psychopharmacol 2001, 15:231-236.
17. Cruz S.L., Soberanes-Chavez P., Paez-Martinez N., Lopez-Rubalcava C. Toluene has antidepressant-like actions in two animal models used for the screening of antidepressant drugs. Psychopharmacology (Berl) 2009, 204:279-286.
18. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 2005, 29:547-569.
19. Chao H.M., Ma L.Y., McEwen B.S., Sakai R.R. Regulation of glucocorticoid receptor and mineralocorticoid receptor messenger ribonucleic acids by selective agonists in the rat hippocampus. Endocrinology 1998, 139:1810-1814.
20. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 1993, 18:1-32.
21. Chaouloff F. Regulation of 5-HT receptors by corticosteroids: where do we stand?. Fundam Clin Pharmacol 1995, 9:219-233.
22. Chaouloff F. Serotonin, stress and corticoids. J Psychopharmacol 2000, 14:139-151.
23. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
24. de Gortari P., Uribe R.M., Garcia-Vazquez A., Aguilar-Valles A., Martinez A., Valdes A., et al. Amygdala kindling differentially regulates the expression of the elements involved in TRH transmission. Neurochem Int 2006, 48:31-42.
25. de Kloet E.R., de Jong I.E., Oitzl M.S. Neuropharmacology of glucocorticoids: focus on emotion, cognition and cocaine. Eur J Pharmacol 2008, 585:473-482.
26. de Kloet E.R., de Kock S., Schild V., Veldhuis H.D. Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary-adrenal axis at different brain sites. Neuroendocrinology 1988, 47:109-115.
27. de Kloet E.R., Derijk R. Signaling pathways in brain involved in predisposition and pathogenesis of stress-related disease: genetic and kinetic factors affecting the MR/GR balance. Ann N Y Acad Sci 2004, 1032:14-34.
28. de Kloet E.R., Fitzsimons C.P., Datson N.A., Meijer O.C., Vreugdenhil E. Glucocorticoid signaling and stress-related limbic susceptibility pathway: about receptors, transcription machinery and microRNA. Brain Res 2009, 1293:129-141.
29. de Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998, 19:269-301.
30. Degroot A., Treit D. Anxiety is functionally segregated within the septo-hippocampal system. Brain Res 2004, 1001:60-71.
31. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995, 121:66-72.
32. Duncan G.E., Johnson K.B., Breese G.R. Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. J Neurosci 1993, 13:3932-3943.
33. Ebner K., Singewald G.M., Whittle N., Ferraguti F., Singewald N. Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission. Neuropsychopharmacology 2008, 33:1929-1941.
34. Espejo E.F., Minano F.J. Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test. Neuroscience 1999, 88:609-615.
35. Estrada-Camarena E., Contreras C.M., Saavedra M., Luna-Baltazar I., Lopez-Rubalcava C. Participation of the lateral septal nuclei (LSN) in the antidepressant-like actions of progesterone in the forced swimming test (FST). Behav Brain Res 2002, 134:175-183.
36. Gall C., Moore R.Y. Distribution of enkephalin, substance P, tyrosine hydroxylase, and 5-hydroxytryptamine immunoreactivity in the septal region of the rat. J Comp Neurol 1984, 225:212-227.
37. Gesing A., Bilang-Bleuel A., Droste S.K., Linthorst A.C., Holsboer F., Reul J.M. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. J Neurosci 2001, 21:4822-4829.
38. Gillman P.K. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 2007, 151:737-748.
39. Gray J.A. The neuropsychology of anxiety. Issues Ment Health Nurs 1985, 7:201-228.
40. Hansson A.C., Fuxe K. Biphasic autoregulation of mineralocorticoid receptor mRNA in the medial septal nucleus by aldosterone. Neuroendocrinology 2002, 75:358-366.
41. Hemby S.E., Lucki I., Gatto G., Singh A., Thornley C., Matasi J., et al. Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters. J Pharmacol Exp Ther 1997, 282:727-733.
42. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003, 24:151-180.
43. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1201-1213.
44. Holmes M.C., Yau J.L., French K.L., Seckl J.R. The effect of adrenalectomy on 5-hydroxytryptamine and corticosteroid receptor subtype messenger RNA expression in rat hippocampus. Neuroscience 1995, 64:327-337.
45. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996, 17:187-205.
46. Hugin-Flores M.E., Steimer T., Aubert M.L., Schulz P. Mineralo- and glucocorticoid receptor mRNAs are differently regulated by corticosterone in the rat hippocampus and anterior pituitary. Neuroendocrinology 2004, 79:174-184.
47. Hugin-Flores M.E., Steimer T., Schulz P., Vallotton M.B., Aubert M.L. Chronic corticotropin-releasing hormone and vasopressin regulate corticosteroid receptors in rat hippocampus and anterior pituitary. Brain Res 2003, 976:159-170.
48. Iversen L. Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 2006, 147(Suppl. 1):S82-S88.
49. Jefferys D., Copolov D., Funder J.W. Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomy. Eur J Pharmacol 1984, 103:205-210.
50. Jefferys D., Copolov D., Irby D., Funder J. Behavioural effect of adrenalectomy: reversal by glucocorticoids or [D-Ala2,Met5]enkephalinamide. Eur J Pharmacol 1983, 92:99-103.
51. Jenck F., Moreau J.L., Mutel V., Martin J.R., Haefely W.E. Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 1993, 231:223-229.
52. Jequier E., Lovenberg W., Sjoerdsma A. Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Mol Pharmacol 1967, 3:274-278.
53. Joels M., Krugers H., Karst H. Stress-induced changes in hippocampal function. Prog Brain Res 2008, 167:3-15.
54. Joels M., Krugers H.J., Lucassen P.J., Karst H. Corticosteroid effects on cellular physiology of limbic cells. Brain Res 2009, 1293:91-100.
55. Johnson D.A., Grant E.J., Ingram C.D., Gartside S.E. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant. Biol Psychiatry 2007, 62:1228-1235.
56. Kalia M. Neurobiological basis of depression: an update. Metabolism 2005, 54:24-27.
57. Karandrea D., Kittas C., Kitraki E. Forced swimming differentially affects male and female brain corticosteroid receptors. Neuroendocrinology 2002, 75:217-226.
58. Kellner M., Wiedemann K. Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy. Eur J Pharmacol 2008, 583:372-378.
59. Khaksari M., Rashidy-Pour A., Vafaei A.A. Central mineralocorticoid receptors are indispensable for corticosterone-induced impairment of memory retrieval in rats. Neuroscience 2007, 149:729-738.
60. Kirby L.G., Allen A.R., Lucki I. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 1995, 682:189-196.
61. Kohler C., Chan-Palay V., Steinbusch H. The distribution and origin of serotonin-containing fibers in the septal area: a combined immunohistochemical and fluorescent retrograde tracing study in the rat. J Comp Neurol 1982, 209:91-111.
62. Kokras N., Antoniou K., Dalla C., Bekris S., Xagoraris M., Ovestreet D.H., et al. Sex-related differential response to clomipramine treatment in a rat model of depression. J Psychopharmacol 2009, 23:945-956.
63. Korte S.M., de Boer S.F., de Kloet E.R., Bohus B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 1995, 20:385-394.
64. Korte S.M., de Kloet E.R., Buwalda B., Bouman S.D., Bohus B. Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. Eur J Pharmacol 1996, 301:19-25.
65. Lai M., McCormick J.A., Chapman K.E., Kelly P.A., Seckl J.R., Yau J.L. Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture. Neuroscience 2003, 118:975-984.
66. Lanfumey L., Mongeau R., Cohen-Salmon C., Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 2008, 32:1174-1184.
67. Lopez-Rubalcava C. Pre- or postsynaptic activity of 5-HT1A compounds in mice depends on the anxiety paradigm. Pharmacol Biochem Behav 1996, 54:677-686.
68. Lopez-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 2000, 22:191-199.
69. Lopez-Rubalcava C., Saldivar A., Fernandez-Guasti A. Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics. Pharmacol Biochem Behav 1992, 43:433-440.
70. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997, 8:523-532.
71. Marvan M.L., Contreras C.M. Clomipramine increases firing rate in lateral septal neurons related with hippocampus. Physiol Behav 1993, 54:13-18.
72. Massol J., Martin P., Chatelain F., Puech A.J. Tricyclic antidepressants, thyroid function, and their relationship with the behavioral responses in rats. Biol Psychiatry 1990, 28:967-978.
73. Meijer O.C., de Kloet E.R. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 1998, 12:1-20.
74. Meijer O.C., de Kloet E.R. Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus. Eur J Pharmacol 1994, 266:255-261.
75. Meijer O.C., Williamson A., Dallman M.F., Pearce D. Transcriptional repression of the 5-HT1A receptor promoter by corticosterone via mineralocorticoid receptors depends on the cellular context. J Neuroendocrinol 2000, 12:245-254.
76. Menard J., Treit D. Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests. Physiol Behav 1996, 60:845-853.
77. Nemeroff C.B., Vale W.W. The neurobiology of depression: inroads to treatment and new drug discovery. J Clin Psychiatry 2005, 66(Suppl. 7):5-13.
78. Nikisch G. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Neuro Endocrinol Lett 2009, 30:11-16.
79. Ninomiya E.M., Martynhak B.J., Zanoveli J.M., Correia D., da Cunha C., Andreatini R. Spironolactone and low-dose dexamethasone enhance extinction of contextual fear conditioning. Progress in Neuro-Psychopharmacology and Biological Psychiatry(2011), 34(7), pages:1229-1235, DOI: 10.1016/j.pnpbp.2010.06.025.
80. Oitzl M.S., van Haarst A.D., de Kloet E.R. Behavioral and neuroendocrine responses controlled by the concerted action of central mineralocorticoid (MRS) and glucocorticoid receptors (GRS). Psychoneuroendocrinology 1997, 22(Suppl. 1):S87-S93.
81. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 1999, 147:162-167.
82. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008, 31:464-468.
83. Paul I.A., Duncan G.E., Kuhn C., Mueller R.A., Hong J.S., Breese G.R. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake. J Pharmacol Exp Ther 1990, 252:997-1005.
84. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego.
85. Pei Q., Zetterstrom T., Fillenz M. Tail pinch-induced changes in the turnover and release of dopamine and 5-hydroxytryptamine in different brain regions of the rat. Neuroscience 1990, 35:133-138.
86. Poleszak E. Modulation of antidepressant-like activity of magnesium by serotonergic system. J Neural Transm 2007, 114:1129-1134.
87. Porsolt R.D., Brossard G., Hautbois C., Roux S. Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci 2001, [Chapter 8: Unit 8 10A].
88. Quirarte G.L., Roozendaal B., McGaugh J.L. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci USA 1997, 94:14048-14053.
89. Reneric J.P., Lucki I. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl) 1998, 136:190-197.
90. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
91. Risold P.Y., Swanson L.W. Chemoarchitecture of the rat lateral septal nucleus. Brain Res Brain Res Rev 1997, 24:91-113.
92. Robertson D.A., Beattie J.E., Reid I.C., Balfour D.J. Regulation of corticosteroid receptors in the rat brain: the role of serotonin and stress. Eur J Neurosci 2005, 21:1511-1520.
93. Rodriguez-Landa J.F., Contreras C.M., Bernal-Morales B., Gutierrez-Garcia A.G., Saavedra M. Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABAA receptor in the rat. J Psychopharmacol 2007, 21:76-84.
94. Rodriguez-Landa J.F., Contreras C.M., Garcia-Rios R.I. Allopregnanolone microinjected into the lateral septum or dorsal hippocampus reduces immobility in the forced swim test: participation of the GABAA receptor. Behav Pharmacol 2009, 7:614-622.
95. Rogel-Salazar G., Lopez-Rubalcava C. Evaluation of the anxiolytic-like effects of clomipramine in two rat strains with different anxiety vulnerability (Wistar and Wistar-Kyoto rats): participation of 5-HT1A receptors. Behav Pharmacol 2011, 22:136-146.
96. Scinska A., Swiecicki L., Korkosz I., Mierzejewski P., Kolaczkowski M. Immobility in the tail suspension test predicts quinine but not saccharin intake in mice. Neurosci Lett 2009, 461:285-288.
97. Schreiber R., de Vry J. Neuroanatomical basis for the antidepressant-like effects of the 5-HT(1A) receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav Pharmacol 1993, 4:625-636.
98. Seggie J., Uhlir I., Brown G.M. Adrenal stress responses following septal lesions in the rat. Neuroendocrinology 1974, 16:225-236.
99. Semont A., Fache M., Hery F., Faudon M., Youssouf F., Hery M. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-l-tryptophan or fluoxetine. J Neuroendocrinol 2000, 12:736-744.
100. Semont A., Fache M., Ouafik L., Hery M., Faudon M., Hery F. Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structures. Neuroendocrinology 1999, 69:121-128.
101. Sheehan T.P., Chambers R.A., Russell D.S. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Brain Res Rev 2004, 46:71-117.
102. Shelton R.C. The molecular neurobiology of depression. Psychiatr Clin North Am 2007, 30:1-11.
103. Singewald G.M., Rjabokon A., Singewald N., Ebner K. The modulatory role of the lateral septum on neuroendocrine and behavioral stress responses. Neuropsychopharmacology 2011, 36:793-804.
104. Singh V.B., Corley K.C., Phan T.H., Boadle-Biber M.C. Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment. Brain Res 1990, 516:66-76.
105. Staiger J.F., Nurnberger F. Pattern of afferents to the lateral septum in the guinea pig. Cell Tissue Res 1989, 257:471-490.
106. Szewczyk B., Poleszak E., Wlaz P., Wrobel A., Blicharska E., Cichy A., et al. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:323-329.
107. Takase L.F., Nogueira M.I., Baratta M., Bland S.T., Watkins L.R., Maier S.F., et al. Inescapable shock activates serotonergic neurons in all raphe nuclei of rat. Behav Brain Res 2004, 153:233-239.
108. Tamburella A., Micale V., Navarria A., Drago F. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1205-1210.
109. Trneckova L., Armario A., Hynie S., Sida P., Klenerova V. Differences in the brain expression of c-fos mRNA after restraint stress in Lewis compared to Sprague-Dawley rats. Brain Res 2006, 1077:7-15.
110. Van den Hooff P., Galvan M. Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro. Br J Pharmacol 1992, 106:893-899.
111. Vargas M.A., St-Louis M., Desgroseillers L., Charli J.L., Boileau G. Parathyroid hormone-related protein(1-34) regulates Phex expression in osteoblasts through the protein kinase A pathway. Endocrinology 2003, 144:4876-4885.
112. Veldhuis H.D., de Korte C.C., De Kloet E.R. Glucocorticoids facilitate the retention of acquired immobility during forced swimming. Eur J Pharmacol 1985, 115:211-217.
113. Wissink S., Meijer O., Pearce D., van Der Burg B., van Der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J Biol Chem 2000, 275:1321-1326.
114. Wright I.K., Upton N., Marsden C.A. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berl) 1992, 109:338-346.
115. Yamada K., Hasuo H., Murakami C., Yasaka Y., Fujimura T., Akasu T. 5-Hydroxytryptamine-induced outward currents mediated via 5-HT(1A) receptors in neurons of the rat dorsolateral septal nucleus. Neurosci Res 2000, 37:307-314.